{"name": "ImmuneXcite",
 "permalink": "immunexcite",
 "crunchbase_url": "http://www.crunchbase.com/company/immunexcite",
 "homepage_url": "http://www.immunexcite.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@immunexcite.com",
 "phone_number": "",
 "description": "",
 "created_at": "Thu Jan 05 05:53:36 UTC 2012",
 "updated_at": "Thu Jan 05 05:53:36 UTC 2012",
 "overview": "\u003Cp\u003EImmuneXcite has developed a proprietary platform technology for enhancing the efficacy of therapeutic monoclonal antibodies for oncological and infectious disease targets.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[143,
       59],
      "assets/images/resized/0016/8883/168883v1-max-150x150.png"],
     [[143,
       59],
      "assets/images/resized/0016/8883/168883v1-max-250x250.png"],
     [[143,
       59],
      "assets/images/resized/0016/8883/168883v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$2.5M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.masshightech.com/stories/2012/01/02/daily11-Fungi-focused-ImmuneXcite-nabs-25M-in-first-funding.html",
    "source_description": "Fungi-focused ImmuneXcite nabs $2.5M in first funding",
    "raised_amount": 2500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 1,
    "funded_day": 4,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}